Literature DB >> 9796059

Serologic responses of young colostrum fed dairy calves to antigens of Pasteurella haemolytica A1.

D C Hodgins1, P E Shewen.   

Abstract

The potential and limitations of early calfhood vaccination to induce active immunity to Pasteurella haemolytica A1 in conventional colostrum fed calves were investigated. Holstein dairy calves (n = 29) were vaccinated at 2 and 4 weeks of age, or at 6 and 8 weeks of age with a commercial culture supernatant vaccine (Presponse, Langford Inc., Guelph, Ont., Canada), or remained unvaccinated as controls. Serum antibody titres were measured using an indirect bacterial agglutination assay, a leukotoxin neutralization assay, and enzyme immunoassays for antibodies of the IgM, IgG1, and IgG2 isotypes binding purified capsular polysaccharide of P. haemolytica A1. Seroconversion (fourfold or greater increase in serum antibody titre) rates were compared using Fisher's exact test. The effects of passive antibody titres and age on response to vaccination were assessed by linear modelling. Vaccination at 2 and 4 weeks of age was associated with 40%, and 0% of calves seroconverting on the basis of agglutinating antibody titres, and leukotoxin neutralizing titres respectively, and 50%, 0%, and 0% seroconverting on the basis of IgM, IgG1 and IgG2 antibodies to capsular polysaccharide, respectively. Agglutinating antibody responses were not related to prevaccination antibody titres, or to age at vaccination. Higher responses (p = 0.08) to leukotoxin were observed in older calves (after taking differences in prevaccination titres into account). Statistical analyses of responses to capsular polysaccharide among calves with comparable prevaccination IgG1 antibody titres revealed significantly higher IgM, IgG1 and IgG2 responses in older calves. Rising titres of IgM antibodies in nonvaccinated calves after 5 weeks of age suggest natural exposure to P. haemolytica A1 or antigens which result in serologic cross-reactions as a means of priming immune responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9796059     DOI: 10.1016/s0264-410x(98)00086-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Vaccination of neonatal colostrum-deprived calves against Pasteurella haemolytica A1.

Authors:  D C Hodgins; P E Shewen
Journal:  Can J Vet Res       Date:  2000-01       Impact factor: 1.310

2.  Field Trial of Antibody Response To Inactivated Bacterial Vaccine in Young Holstein Calves: Influence of Animal Health Status.

Authors:  Kazusa Mori; Konosuke Otomaru; Toshihide Kato; Osamu Yokota; Hiromichi Ohtsuka
Journal:  J Vet Res       Date:  2022-03-25       Impact factor: 2.058

3.  Vaccination of piglets up to 1 week of age with a single-dose Mycoplasma hyopneumoniae vaccine induces protective immunity within 2 weeks against virulent challenge in the presence of maternally derived antibodies.

Authors:  Stephen Wilson; Leen Van Brussel; Gillian Saunders; Paul Runnels; Lucas Taylor; Dan Fredrickson; Jeremy Salt
Journal:  Clin Vaccine Immunol       Date:  2013-03-13

4.  Field Trial of Primary and Booster Dose of Inactivated Vaccine Against Bovine Respiratory Bacteria in Young Holstein Calves.

Authors:  Kazusa Mori; Toshihide Kato; Osamu Yokota; Hiromichi Ohtsuka
Journal:  J Vet Res       Date:  2020-06-16       Impact factor: 1.744

5.  Maternally and naturally acquired antibody to Mannheimia haemolytica in Japanese Black calves.

Authors:  Konosuke Otomaru; Sei Kubota; Makiko Tokimori
Journal:  J Vet Med Sci       Date:  2013-08-20       Impact factor: 1.267

6.  Challenges in mucosal vaccination of cattle.

Authors:  P E Shewen; L Carrasco-Medina; B A McBey; D C Hodgins
Journal:  Vet Immunol Immunopathol       Date:  2008-10-17       Impact factor: 2.046

Review 7.  Neonatal immune development in the calf and its impact on vaccine response.

Authors:  Christopher C L Chase; David J Hurley; Adrian J Reber
Journal:  Vet Clin North Am Food Anim Pract       Date:  2008-03       Impact factor: 3.357

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.